retatrutide clinical trial results weight loss 2024 2025 press release 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Triple hormone receptor agonist retatrutide

Theres data to suggest that inflammation is a driver in Alzheimers disease

It's Tuesday, January 6th at 10am in New York

Read more: #WuXiAppTec #GLP-1 #DrugDevelopment #MetabolicMedicine To view or add a comment, sign in 36,516 followers At Investor Day, retina specialist Darius M

By protecting cells and assisting in their detoxification processes, it indirectly supports the regeneration of hair follicle cells, encouraging them to remain in the active growth (anagen) phase for longer

However, people can acquire the condition, too

Baseline Characteristics of the Included Randomized Controlled Trials and Participants Table 2